T

Tethys Bioscience

21 employees

Tethys BioScience develops and commercializes biological markers for use in the diagnosis of metabolic diseases.

Investor insights

Sectors invested in

Immunotherapy1
Biopharma1
Health Care1
Tropical Diseases1
Prophylactic vaccines1
Biotechnology1
Infectious Diseases1
Therapeutic vaccines1
Lentiviral vectors1
Oncology1

Funding rounds participated in

$20M sweet spot round size

Most of their 1 investments are in rounds between $20M and $20M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
disease prevention
diabetes
research

Date founded

2002

Investments made

T

THERAVECTYS raised $20M on October 16, 2013

Investors: Tethys Bioscience

Funding rounds raised

Total raised

$25M

from 13 investors over 13 rounds

T

Tethys Bioscience raised $12M on January 1, 2012

Investors: Armentum Partners

T

Tethys Bioscience raised $23M on July 21, 2010

Investors: Greenspring Associates and Paul Capital Partners

T

Tethys Bioscience raised $10M on July 21, 2010

Investors: Oxford Finance LLC

T

Tethys Bioscience raised $25M on November 9, 2009

Investors: Intel Capital, Mohr Davidow Ventures, Aeris Capital AG and Kleiner Perkins

T

Tethys Bioscience raised undisclosed on January 10, 2008

Investors: Greenspring Associates, Intel Capital, Mohr Davidow Ventures and Kleiner Perkins

T

Tethys Bioscience raised $5.4M on October 31, 2005

Investors: Mohr Davidow Ventures

FAQ